Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023, Verve was recognized as a "Best Places to Work" by the Boston Globe. Verve is headquartered in Boston, Massachusetts.
View Top Employees from Verve TherapeuticsWebsite | http://www.vervetx.com |
Employees | 275 (252 on RocketReach) |
Founded | 2018 |
Address | 201 Brookline Ave Suite 601, Boston, Massachusetts 02215, US |
Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
Industry | Biotechnology Research, Biotechnology, Science and Engineering |
Looking for a particular Verve Therapeutics employee's phone or email?
252 people are employed at Verve Therapeutics.
Verve Therapeutics is based in Boston, Massachusetts.